Lindsay Clancy & the 13 Medications Prescribed to Her: 48 Hours of No Sleep After New Med

Understanding the range of mental health conditions that follow childbirth is critical for accurate diagnosis and effective treatment. Postpartum depression, postpartum psychosis, and postpartum OCD have unique characteristics, symptoms, and clinical considerations that can easily be misunderstood both by sufferers and those around them.

Postpartum Psychosis vs. Postpartum Depression: Different Conditions, Treatments, and Clinical Understanding

Postpartum Depression Affects 1 In 8, Causing Depressed Mood and Loss of Interest

Postpartum depression is relatively common, affecting about one in eight people who give birth. Sufferers describe deep sadness, loss of connection with their children, and difficulty feeling authentic happiness or enjoyment. Lindsey, for example, shares in her notes that she feels she is not mothering her third child as she did her first, leading to guilt and resentment she knows isn’t fair. She expresses sadness over stopping breastfeeding, a perceived disconnect with her baby Cal, and persistent exhaustion compounded by being unable to nap during the day while caring for other children. Lindsey also describes internal conflict about having more children, fear of starting medication, and a yearning to recapture joy and connection in her parenting and marriage. She relates ongoing struggles with self-care, fun, and partnership, underscoring the pervasive impact postpartum depression has on mood, daily functioning, and family relationships.

Postpartum Psychosis, Affecting 1-2 per 1,000 Births, Involves Hallucinations, Delusions, and Disorganized Thinking, Unlike Depression

In contrast, postpartum psychosis is rare, affecting about one to two people per 1,000 births. Unlike postpartum depression, postpartum psychosis is marked by hallucinations (often religious in nature), delusions, and disorganized thinking. Common manifestations include beliefs that the devil is targeting the baby, or that the spouse is a religious figure whose prophecy can only be fulfilled through the baby's death. Other delusions involve paranoia about someone kidnapping the child and a profound belief that only the parent can protect the baby. Presentations can vary greatly, and subtle symptoms may include a vague sense that something is wrong, intrusive thoughts, or the experience of sinking into depression before disturbing or disorganized thoughts emerge.

Distinction Between Conditions Is Critical Because Postpartum Psychosis Can Include Symptoms of Depression With Psychotic Features, Making It Appear Similar to Postpartum Depression When the Psychotic Component Is Intermittent or Hidden

A major challenge for clinicians is that postpartum psychosis can include elements of depression or anxiety. The psychotic features can be intermittent or hidden, making it difficult to distinguish from postpartum depression, especially in brief or routine clinical encounters. Individuals may present periods of completely normal functioning, such that the psychotic symptoms are not apparent during most appointments. Many case reports and online forums show that loved ones and even healthcare providers may only observe depression and anxiety, while the psychotic component remains unnoticed unless it manifests during a specific assessment window.

Postpartum Psychosis May Go Undetected Due to Normal Functioning Periods During Appointments

Patients with postpartum psychosis may have long lucid periods, and since the psychotic break can be brief, it may not be revealed during a typical clinical check-in. This increases the risk of misdiagnosis and delayed treatment.

Manifestations of Postpartum Psychosis Include Religious Hallucinations, Such as Beliefs About the Devil Targeting the Baby or a Spouse Being a Religious Figure, Along With Fears of Baby Kidnapping, Though Presentations Vary Significantly

Details such as religious hallucinations—believing the devil is coming for the baby, or that a spouse is the reincarnation of a religious figure—can be especially distinctive clinical markers, although presentations differ significantly between individuals.

Subtle Symptoms in Postpartum Psychosis: Intrusive Thoughts Over Hallucinations

Some experience more subtle forms, with depressive symptoms followed by intrusive or bizarre thoughts rather than vivid hallucinations or disorganized behavior. For some, this manifests as a sense that something is “growing in their lungs” or a pervasive inability to breathe easily, accompanied by adaptation to these sensations without clear recognition of psychosis.

Lack of Diagnostic Tool For Postpar ...

Lindsay Clancy Prescribed [restricted term] For Postpartum Anxiety but Faced Severe Reactions, Prompting Medication Change

Lindsay Got a [restricted term] Prescription From Dr. Jennifer Tufts Via Telehealth In September 2022, Hesitant to Take It While Breastfeeding, Four Months After Her Third Child's Birth

In September 2022, four months postpartum after the birth of her third child, Lindsay Clancy had her first telehealth appointment with Dr. Jennifer Tufts. She expressed significant anxiety and some concerns about starting medication, especially given her past experience with [restricted term] and her desire to continue breastfeeding. Dr. Tufts diagnosed Lindsay with generalized anxiety disorder and an adjustment disorder with depressed mood, prescribing [restricted term]—a selective serotonin reuptake inhibitor (SSRI)—citing it as a first-line treatment for anxiety and a preferred option for breastfeeding women.

[restricted term] Dose Increased: 25 Mg to 50 Mg Following Standard SSRI Protocol

Lindsay was initially prescribed 25 mg of [restricted term], a common starting dose. Soon after, this dose was increased to 50 mg, which follows standard protocol for SSRIs and is not an abnormal dosage.

Insomnia, Worsening Anxiety, and Mental Fog In Lindsay After Starting [restricted term]

After starting [restricted term], Lindsay quickly began experiencing severe side effects, particularly following the dose increase. She reported extreme insomnia, at times remaining awake for 48 hours. Additional symptoms included racing thoughts, worsening anxiety, mental fog, depressed mood, persistent crying, diarrhea, stomach aches, loss of appetite, and increasing paranoia. These symptoms were so severe that they not only worsened her baseline condition but also made daily functioning extremely difficult. Lindsay shared with Dr. Tufts that she felt awful and was terrified to start another new medication.

Reported Symptoms: Depressed Mood, Crying, Diarrhea, Stomach Issues, Appetite Loss, and Increased Paranoia, Worsening Baseline Condition

Lindsay’s condition deteriorated significantly on [restricted term]. Dr. Tufts noted in her records that Lindsay had worsening insomnia, food aversion, stomach and digestive issues, increased anxiety, persistent crying, and more profound depression. Lindsay also described having mental fog and being fearful of developing suicidal thoughts or being alone, and she could not distinguish whether her anxiety was a pre-existing condition or a result of [restricted term].

Dr. Tufts Stopped [restricted term] After One Week At a Higher Dose Without Tapering Down, Appropriate Given the Low Dose and Severe Reactions

After about a week at the higher dose, Lindsay and Dr. Tufts decided to discontinue [restricted term] due to the intolerable side effects. Although SSRIs such as [restricted term] typically require gradual tapering, the low dosage and short treatment period made abrupt cessation safe, according to established medical guidance.

Discontinuation of [restricted term]: Dr. Tufts Prescribed Benzodiazepines, Antihistamines, Antidepressants For Lindsay's Anxiety and Insomnia

Lindsay's [restricted term] Prescription: Anxiety Relief With Dependence Risks

Following the discontinuation of [restricted term], Dr. Tufts prescribed [restricted term] ([restricted term]), a benzodiazepine, at 0.5 mg on an as-needed (PRN) basis. Lindsay found that [restricted term] effectively and almost immediately reduced her anxiety and made her feel “like herself again.” She wrote in a postpartum forum that it was the only medication that truly helped her anxiety. However, she also recognized the significant dependence risks tied to benzodiazepines and that [restricted term] could not serve as a long-term solution.

[restricted term]: Non-controlled Antihistamine For Sleep & Anxiety Management

Because [restricted term] did not resolve her insomnia, Lindsay tried over-the-counter Benadryl for sleep. Dr. Tufts then shifted her to [restricted term] (25 mg PRN), a prescription antihistamine also used for anxiety and sleep, as an alternative to Benadryl. Lindsay was advised not to take [restricted term] and Benadryl together. The plan was for Lindsay to use [restricted term] only when anxiety was overwhelming and to rely on [restricted term] for sleep.

[restricted term], a Daily Anti-Anxiety Medication, Was Expected to Take Effect In One to Two Weeks, Though Lindsay Was Hesitant to Start It

Dr. Tufts also prescribed [restricted term] ([restricted term]), a daily anti-anxiety medication, at 5 mg twice daily. Its therapeutic benefits typically emerge after one or two weeks. Lindsay was hesitant to start [restricted term] because of her previous negative reaction to [restricted term] and general apprehension about taking new medications.

Complexity of Medication Regimen Affected Lindsay's Compliance

Between September 2022 and January 2023, Lindsay was prescribed thirteen different medications, some as direct replacements for others. This complex regimen, combined with her reluctance to start new medications, appears to have impacted her compliance. There was evidence that she filled [restricted term] prescriptions but did not consistently take the medication; two pills were missing from one bottle, but the rest remained, and toxicology did not confirm its presence in her system as of late January 2023. It is unclear if or when she took any [restricted term], and no such usage was noted in provider records, adding further uncertainty.

Benzodiazepines Like [restricted ...

Dr. Jennifer Tufts Listed As Interested in Postpartum Psychiatry Despite Minimal Experience

When Dr. Jennifer Tufts began treating Lindsay Clancy, she had just completed her residency and had been working independently as a psychiatrist for only a little more than a month. During questioning, defense attorney Reddington pressed Tufts on her practical experience, asking how many women she treated for postpartum depression and postpartum psychosis before meeting Lindsay. Tufts admitted to treating only "maybe a couple" of postpartum depression cases in that time and none for postpartum psychosis, citing its rarity. She added that she treated many during her residency but none as an independent psychiatrist prior to Lindsay.

Reddington raised concerns about the clinic’s decision to list Dr. Tufts as having an "interest" in postpartum psychiatry on its website despite her very limited post-residency experience. The defense characterized this as reckless, given the complexity and rarity of postpartum psychosis, and suggested that listing an interest in a domain of care does not equate to expertise, especially without formal specialized training in perinatal mood disorders.

During testimony, Tufts maintained that she did not claim to be a postpartum expert, emphasizing the website described it as an interest rather than a specialization. However, critics—including Stephanie Soo—pointed out that listing "postpartum" as an interest without adequate experience is misleading and inappropriate, especially for such a complex and sensitive clinical area.

Telehealth Limited Dr. Tufts' Ability to Observe Lindsay's Physical Distress, Creating Assessment Barriers

All fourteen appointments between Dr. Tufts and Lindsay Clancy were conducted via telehealth between September and January. Reddington argued that the telehealth format made it impossible for Tufts to directly observe important indicators of Lindsay's physical distress, such as hand wringing or leg bouncing—common manifestations of emotional stress. Tufts confirmed she could not see Lindsay's hands or legs due to the camera’s angle. Despite the severity of Lindsay’s symptoms, Tufts never recommended an in-person appointment, maintaining that office visits could be arranged at the patient's request.

The defense used this reliance on telehealth to argue that Lindsay was inadequately assessed and that the medium was inappropriate for a complex postpartum case needing intensive, nuanced observation and potential intervention.

Dr. Tufts' Documentation Lacked Detail On Lindsay's Psychiatric Status and Risks

Reddington scrutinized Dr. Tufts’ medical notes for lacking clarity and detailed documentation regarding Lindsay's psychiatric status and risk level. Notably, the chart described Lindsay as "close to SI" (suicidal ideation), a term the defense criticized for its ambiguity and legal insufficiency. The distinction between "SI" and "close to SI" was mulled over at length, with Reddington arguing that such documentation is vague and could be used against Tufts, whereas proper clarity and supporting notes were required.

Further gaps included Dr. Tufts being unaware of Lindsay calling the suicide prevention hotline twice—raising concerns she failed to ask or document Lindsay’s help-seeking behaviors or crisis contacts outside the office. Additionally, Tufts’ notes neglected to detail Lindsay's adverse medication reactions, their timing, severity, and symptom patterns, which could have prompted earlier recognition of a possible manic or mixed state, critical in postpartum presentations.

Dr. Tufts Lacked Standardized Screening Tools For Postpartum Mental Health and Omitted Input From Lindsay's Other Healthcare Providers, Limiting Her Psychiatric Assessment

Dr. Tufts did not utilize the Edinburgh Postnatal Depression Scale (EPDS), a standard screening tool for postpartum depression. Instead, she used the PHQ-9, which screens for general depression but lacks sensitivity for postpartum-specific symptoms. While Tufts said this was dictated by the clinic’s protocols, Reddington questioned whether she even knew how the EPDS was scored. Tufts admitted unfamiliarity with the details, which the defense seized upon as evidence against her expertise in postpartum mental health. Stephanie Soo supported the idea that even if clinic practice doesn’t employ the EPDS, any provider listing postpartum as an interest should understand the tool and its relevance for patient care.

Furthermore, Dr. Tufts did not obtain releases or communicate with Lindsay’s other mental health providers, despite Lindsay reporting additional psychiatric treatments. This omission deprived the assessment of potential corroborating or contradictory information and missed the opportunity for coordinated, comprehensive care—especially vital for complex postpartum presentations.

Concerns Raised About Dr. Tufts' Testimony

On the witness stand, Dr. Tufts defended her notes and clinical decisions. She stood by her documentation practices, despite concerns over ambiguity and lack of detail. Reddington questioned her about the FDA’s black box warning on [restricted term] ([restricted term]) and challenged her testimony that the increased suicide risk identified by the FDA for SSRI use was only rel ...

Ssris Can Trigger Manic Episodes in Undiagnosed Bipolar Disorder, Possibly Changing Unipolar Depression to Bipolar

SSRIs like [restricted term] can trigger manic or hypomanic episodes in individuals with an underlying, undiagnosed bipolar disorder. This effect often reshapes what was believed to be unipolar depression into a diagnosis of bipolar disorder after the fact. Stephanie Soo notes the FDA’s clear guidance: in patients with bipolar disorder, treating a depressive episode exclusively with SSRIs can precipitate a mixed manic episode. The FDA instructs practitioners to screen patients for any personal or family history of bipolar disorder, mania, or hypomania before prescribing SSRIs.

Clinical anecdotes and patient testimonies abound. Many report that they were initially treated for depression with SSRIs, only to experience an antidepressant-induced mania. This led doctors to revise the diagnosis from major depressive disorder to bipolar disorder, typically type II. The mechanism is that SSRIs can activate serotonin pathways in vulnerable individuals, pushing mood from depression to hypomania or full mania. Reports from [restricted term] users describe rapid-onset energy, feelings of clarity, and intense productivity, sometimes overnight.

Hypomania and Mania May Seem Like Functioning Improvements, Making These States Hard to Recognize As Pathological Mood Disturbances Needing Intervention

Hypomanic and manic states often present as periods of elevated mood, increased activity, reduced need for sleep, racing thoughts, and heightened energy. The changes may appear, even to outside observers, as positive improvements: increased productivity, launching several new projects, speaking rapidly, needing only a few hours of sleep, and a confident sense of wellbeing. The person may subjectively experience a conviction of capability and clarity. However, attention may become fragmented, with frequent switches between projects. The dangerous point is that these states feel and appear beneficial and can mask underlying pathology, delaying recognition and necessary intervention.

Critically, the pleasant and productive aspects of hypomania are deceptive. Extended manic episodes often lead to severe depression or mixed states and, in some cases, self-harm. The initial sense of improved functionality blinds both the patient and healthcare providers to the seriousness of the underlying mood instability.

Mixed Mania: Dangerous Bipolar Mood With Rapid Cycling and Elevated Suicide Risk

Mixed mania is among the most dangerous manifestations of bipolar disorder. It is characterized by simultaneous or rapidly alternating manic symptoms (such as racing thoughts, high energy, and irritability) and depressive symptoms (hopelessness, guilt, and suicidal ideation). This produces a uniquely hazardous mood state where the energy and impulsivity of mania combine with the despair of depression. The risk of suicide and self-harm is particularly high in mixed mania, higher than in pure depressive or manic episodes. Rapid cycles of outward energy, irritation, despair, and social withdrawal mark mixed mania, demanding aggressive and specialized treatment.

High-Risk Postpartum for Bipolar Episodes in Vulnerable Women, Necessitating Careful Screening and Diagnosis

The postpartum period is a particularly high-risk time for the emergence of bipolar episodes in previously undiagnosed individuals, especially women. Many experience their first episode of bipolar disorder after childbirth. Hormonal shifts, severe sleep deprivation, physical recovery, social isolation, and parenting stress all converge to drive mood instability. Women with a history or latent risk of bipolar disorder, especially bipolar I, face higher rates of postpartum psychosis. Sleep deprivation in new mothers is a known accelerator for triggering mania in those with underlying bipolar vulnerability.

Postpartum Bipolar Disorder Often Misdiagnosed Due to Atypical Mania

Postpartum bipolar disorder often presents atypically, with mixed mood states that providers may misidentify as severe depression. These episodes may appear as rapid cycling, reactivity, and subtle activation layered over clinical depression. Many healthcare providers, trained to look for postpartum depression, may miss the activation and impulsivity of postpartum bipolar disorder during brief clinical assessments focused on depressive symptoms. This can result in continued SSRI use, which can worsen bipolar disorder when not balanced by mood stabilizers. Distinguishing severe postpartum depression with anxiety from postpartum bipolar depression with activation is a subtle but clinically crucial challenge.

[restricted term]-Induced Bipolar Disorder in Focus Regarding Lindsay Clancy's Psychiatric Care and Crisis原因 Debates

The crux of the debate around Lindsay Clancy’s mental health care is whether she suffered from unipolar postpartum depression or undiagnosed bipolar disorder unmasked by SSRI use. Defense ...

The case of Lindsay Clancy reveals deep systemic issues in psychiatric care, medication management, and emergency mental health intervention, especially in the postpartum context.

Simultaneous Treatment by Multiple Providers Led To Minimal Communication and Potential Medication Interactions For Lindsay Clancy (Sept 2022-Jan 2023)

Psychiatric Care Fragmented by Unshared Records

Lindsay Clancy received care from multiple healthcare providers across different systems, but meaningful communication among her care team was rare. According to Stephanie Soo, unless providers are part of the same healthcare network, they do not have ready access to each other's notes or records. As a result, the few instances of provider communication only happened when clinicians worked at the same hospital and could access shared electronic records.

Dr. Tufts Relied On Lindsay's Verbal Medication Reports

Dr. Tufts and Lindsay’s other providers depended on Lindsay to self-report the medications prescribed to her by others. Providers would ask Lindsay what other medications she was taking, and she would verbally list her prescriptions. Each provider’s awareness of her medication regimen was limited to what Lindsay disclosed, rather than what was recorded electronically by the other prescribers.

Lindsay Received Prescriptions From Multiple Providers Without Coordination or Communication

During this period, Lindsay obtained psychiatric medications from multiple independent providers, none of whom coordinated care with each other except when affiliated with the same system. This fragmentation meant each prescriber acted in isolation, unaware of the broader context of Lindsay’s treatment and total medication exposure.

Poor Communication Left Clinicians Unaware of Lindsay's Full Medication List, Featuring Various Drug Classes For Daily and As-needed Use

Because records were not shared, neither Dr. Tufts nor the other providers had a complete, up-to-date list of all Lindsay's psychiatric medications. She received medications across several drug classes, both for daily and as-needed use, but no provider had the full picture, raising risks of medication interactions and suboptimal treatment.

Care Coordination Failures Due to Limited Provider Access to Electronic Records

This lack of record-sharing stems from systemic issues. Unless providers share an electronic medical record system, they remain siloed from each other. This leaves patients like Lindsay vulnerable when their treatment spans multiple practitioners and healthcare organizations.

Barriers to Coordinated Psychiatric Care From Multiple Independent Providers

The consensus from the hosts and commentators is that this system incentivizes doctors to have brief appointments, quickly prescribe medications, and shift responsibility elsewhere, all while failing to deliver coordinated care. Many professionals reviewing the case sympathize with Dr. Tufts, acknowledging the system’s shortcomings but criticizing her documentation and preparation as especially poor.

Determining Emergency Involuntary Hospitalization For Patients With Suicidal Ideation and a Plan May Miss Those at Risk With Less-Structured Self-Harm Intent

Psychiatric Hold Requires Documented Active Suicidal Thoughts With a Concrete Plan, Method, Timing, and Means; Alone, Neither Element Justifies Involuntary Commitment

Stephanie Soo outlines the criteria for emergency psychiatric hospitalization. A “hold” generally requires not just suicidal thoughts but a specific, articulated plan—including method, timing, and means—that indicates immediate risk.

Plan Requirement Reflects Concern For Avoiding Unnecessary Hospitalization and Respecting Autonomy, but Risks Excluding Those Without Detailed Plans From Emergency Psychiatric Hospitalization

The system is designed to avoid unnecessary involuntary hospitalization, to respect patient autonomy, and to prevent overreach. But this approach risks missing patients in imminent danger who cannot articulate a concrete plan, leaving semantic gaps where risk is unaddressed.

Lindsay Called the Suicide Prevention Hotline Twice but Was Not Hospitalized, Suggesting Clinicians Determined She Didn't Meet Criteria For Emergency Intervention or Chose Not to Pursue Involuntary Hold Procedures

Lindsay called the suicide hotline twice during this period but was not hospitalized. Dr. Tufts was unaware she had made these calls; she never asked about hotline use. Lindsay described intense distress in communication with Dr. Tufts—insomnia, panic, worsening depression, intrusive thoughts, numbness, and the sense that "nothing matters"—but did not express a detailed suicide plan and told her provider she was "not going to do anything” or “not going to act on these thoughts." The absence of a “plan” meant Lindsay did not meet criteria for intervention, and clinicians did not pursue involuntary hold procedures.

Distinction Between "Feeling Suicidal" and Having a "Suicide Plan"

Dr. Tufts explained the distinction between "feeling suicidal"—a sense of hopelessness—and actually “having a plan” for self-harm, which would have prompted more aggressive intervention.

Fear of Disclosure Affecting Custody and Hospitalization May Lead Patients to Minimize Suicidal Ideation

Patients, especially new mothers, worry that disclosure of suicidal ideation could trigger loss of custody due to mandated reporting laws. This fear leads many to under-report or conceal their true feelings.

Psychiatric Holds May Incentivize Patients to Hide Suicide Risks, Fearing Hospitalization More Than Their Impulses, Creating a System Where Transparency Is Punished and Concealment Rewarded

Stephanie Soo notes that patients often know they risk involuntary hospitalization if they reveal specific plans and so usually withhold those details. This creates a system where transparency results in punishment (hospitalization), while concealment is rewarded with avoidance of intervention—even if real ...